What is Xenon Pharmaceuticals Inc's Market Cap?

Xenon Pharmaceuticals Inc's Market Cap is $5.8B, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's Enterprise Value?

Xenon Pharmaceuticals Inc's Enterprise Value is $4.8B, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's EV / EBITDA?

Xenon Pharmaceuticals Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's Revenue (TTM)?

Xenon Pharmaceuticals Inc's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's Net Income (TTM)?

Xenon Pharmaceuticals Inc's Net Income (TTM) is -$409.2M, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's EBITDA?

Xenon Pharmaceuticals Inc's EBITDA is -$439.2M, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's Diluted EPS (TTM)?

Xenon Pharmaceuticals Inc's Diluted EPS (TTM) is -4.23, based on as-reported figures from SEC (XBRL) filings.

What is Xenon Pharmaceuticals Inc's Net Debt?

Xenon Pharmaceuticals Inc's Net Debt is -$930.7M, based on as-reported figures from SEC (XBRL) filings.

Xenon Pharmaceuticals Inc (XENE) Financial Statements

Xenon Pharmaceuticals Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002VBMLS5

XNAS · usd

59.44▼ 0.11 (-0.18%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close59.55

Day's Range58.27 – 60.36

52-Week Range35.60 – 72.66

Volume607.3K

Avg Volume638.8K

Share Statistics

Shares Outstanding

Employees370

ExchangeXNAS

Listed2014-11-05

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Xenon Pharmaceuticals Inc (XENE)

What is Xenon Pharmaceuticals Inc's Market Cap?: Xenon Pharmaceuticals Inc's Market Cap is $5.8B, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's Enterprise Value?: Xenon Pharmaceuticals Inc's Enterprise Value is $4.8B, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's EV / EBITDA?: Xenon Pharmaceuticals Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's Revenue (TTM)?: Xenon Pharmaceuticals Inc's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's Net Income (TTM)?: Xenon Pharmaceuticals Inc's Net Income (TTM) is -$409.2M, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's EBITDA?: Xenon Pharmaceuticals Inc's EBITDA is -$439.2M, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's Diluted EPS (TTM)?: Xenon Pharmaceuticals Inc's Diluted EPS (TTM) is -4.23, based on as-reported figures from SEC (XBRL) filings.
What is Xenon Pharmaceuticals Inc's Net Debt?: Xenon Pharmaceuticals Inc's Net Debt is -$930.7M, based on as-reported figures from SEC (XBRL) filings.